Clinical Site Agreement Template for the United States
Generate a bespoke document
What is a Clinical Site Agreement?
The Clinical Site Agreement is essential for any organization conducting clinical research in the United States. It establishes the legal and operational framework for clinical trials, ensuring compliance with FDA regulations, HIPAA, and other applicable laws. This agreement typically includes detailed provisions for subject enrollment, data collection, safety reporting, compensation, and confidentiality. It's particularly crucial for maintaining regulatory compliance and protecting all parties' interests throughout the research process.
Frequently Asked Questions
Is a Clinical Site Agreement legally binding in the United States?
Yes, a Clinical Site Agreement is a legally binding contract in the United States when properly executed by all parties. It creates enforceable obligations for sponsors, clinical sites, and principal investigators regarding clinical trial conduct, compliance with FDA regulations, and HIPAA requirements. Breach of the agreement can result in legal action, regulatory sanctions, or termination of the clinical trial.
Can a clinical trial proceed without a signed Clinical Site Agreement?
No, conducting a clinical trial without a properly executed Clinical Site Agreement violates FDA regulations and exposes all parties to significant legal and regulatory risks. The agreement is required to establish clear responsibilities for regulatory compliance, patient safety, data integrity, and HIPAA protections. Operating without one can result in FDA enforcement actions and trial suspension.
How does a Clinical Site Agreement differ from an Informed Consent Form?
A Clinical Site Agreement is a contract between the sponsor and research site establishing operational and legal framework for the trial, while an Informed Consent Form is a document provided to individual patients explaining the study. The agreement governs institutional relationships and regulatory compliance, whereas informed consent protects individual patient rights under 21 CFR Part 50.
How long does it typically take to negotiate a Clinical Site Agreement?
Clinical Site Agreement negotiations typically take 2-6 months, depending on the complexity of the trial and institutional requirements. Factors affecting timeline include the number of parties involved, institutional review processes, insurance requirements, and regulatory compliance issues. Academic medical centers often have longer review cycles than private research sites.
Does a Clinical Site Agreement need to comply with HIPAA regulations?
Yes, Clinical Site Agreements must include specific HIPAA compliance provisions when the research involves protected health information. The agreement must address how patient data will be handled, shared, and protected according to HIPAA Privacy and Security Rules. Business Associate Agreements may also be required between covered entities and research sponsors.
Can clinical sites be held liable without proper indemnification clauses?
Yes, clinical sites face significant liability exposure without adequate indemnification provisions in their Clinical Site Agreement. Sites can be held responsible for adverse events, regulatory violations, data breaches, or intellectual property infringement claims. Proper indemnification clauses should protect sites from sponsor-related liabilities while maintaining accountability for site-specific obligations.
Are there specific FDA requirements that must be included in Clinical Site Agreements?
Yes, Clinical Site Agreements must address compliance with multiple FDA regulations including 21 CFR Parts 50 (informed consent), 56 (IRB requirements), 312 (IND regulations), and 812 (IDE regulations for device studies). The agreement must specify responsibilities for adverse event reporting, data integrity, regulatory inspections, and Good Clinical Practice compliance to meet FDA requirements.
About the Clinical Site Agreement
A Clinical Site Agreement is a comprehensive contract that governs the relationship between research sponsors and clinical sites conducting medical research trials in the United States. This essential document establishes clear roles, responsibilities, and obligations for all parties involved in clinical research, ensuring compliance with federal regulations and protecting the rights of research participants.
When do you need this document?
You need a Clinical Site Agreement whenever you're planning to conduct clinical research involving human subjects at a healthcare facility or research institution. This includes pharmaceutical companies sponsoring drug trials, medical device manufacturers testing new products, academic institutions conducting investigator-initiated studies, and contract research organizations managing multi-site trials. The agreement is required before any research activities begin and must be executed prior to subject enrollment, protocol implementation, or any study-related procedures.
Key legal considerations
Your Clinical Site Agreement must address several critical legal elements to ensure comprehensive protection and compliance. The scope of services section should clearly define study procedures, subject enrollment targets, data collection requirements, and timeline expectations. Compliance provisions must outline adherence to Good Clinical Practice guidelines, FDA regulations, and institutional policies. Financial terms should specify payment schedules, budget allocations, and cost responsibilities for study-related activities. Intellectual property clauses need to address data ownership, publication rights, and confidentiality obligations. Indemnification provisions should protect parties from liability arising from protocol violations, adverse events, or regulatory non-compliance. The agreement must also include termination clauses allowing either party to end the relationship under specified circumstances while protecting ongoing subject safety and data integrity.
Legal requirements in United States
United States clinical research is governed by extensive federal regulations that your Clinical Site Agreement must address comprehensively. Under 21 CFR Part 50, you must ensure proper informed consent procedures and participant protections are clearly defined. The agreement must comply with 21 CFR Part 56 requirements for Institutional Review Board oversight, including IRB approval processes and ongoing review obligations. For investigational drugs, 21 CFR Part 312 mandates specific sponsor responsibilities, safety reporting requirements, and protocol compliance measures. Medical device studies must adhere to 21 CFR Part 812 Investigational Device Exemption regulations. HIPAA compliance is mandatory for any research involving protected health information, requiring specific privacy safeguards and data handling procedures. Your agreement should also address state-specific requirements, institutional policies, and Good Clinical Practice standards to ensure complete regulatory compliance throughout the study duration.
GOVERNING LAW
Applicable law
This Clinical Site Agreement is drafted to comply with United States law. Key legislation includes:
Explore 208,390+ legal templates
Explore 208,390+ legal templates
Genie's Security Promise
Genie is the safest place to draft. Here's how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie's AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it